🇺🇸 FDA
Patent

US 11566002

Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same

granted A61KA61K31/403A61K31/4155

Quick answer

US patent 11566002 (Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K31/403, A61K31/4155, A61K31/4192, A61K31/4196